95 related articles for article (PubMed ID: 7139383)
1. [Bronchodilation effects of aminophylline, fenoterol and their combination].
Mayer M; Dúbravová H
Bratisl Lek Listy; 1982 Sep; 78(3):323-33. PubMed ID: 7139383
[No Abstract] [Full Text] [Related]
2. [Relation between indicators of respiratory tract patency and intrapulmonary distribution of ventilation in patients with chronic obstructive bronchopulmonary disease after combined administration of aminophylline and fenoterol].
Mayer M; Dúbrava I; Strmen J; Dúbravová H
Bratisl Lek Listy; 1987 May; 87(5):606-15. PubMed ID: 3651856
[No Abstract] [Full Text] [Related]
3. [(Whole body plethysmographic studies on the bronchospasmolytic effect of injectabls drugs. Comparison of aminophylline, diprophylline and hexoprenaline)].
Kaik G
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):177-85. PubMed ID: 137218
[TBL] [Abstract][Full Text] [Related]
4. Oral sustained-release aminophylline and bronchodilator response to inhaled fenoterol in patients with chronic airflow obstruction.
Carpentiere G; Marino S; Castello F; Zarcone P; Cipolla G; Baldanza C
Chest; 1985 Oct; 88(4):576-8. PubMed ID: 4042711
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of severe bronchial asthma and status asthmaticus with intravenous fenoterol].
Baur X
Dtsch Med Wochenschr; 1988 May; 113(19):763-6. PubMed ID: 3366075
[TBL] [Abstract][Full Text] [Related]
6. [Obstructive respiratory diseases. Comparisons of dose effectiveness of Fenoterol (Berotec) given in diverse oral administration forms].
Hertwig B
ZFA (Stuttgart); 1979 Jan; 55(2):113-22. PubMed ID: 425634
[No Abstract] [Full Text] [Related]
7. [Corticoids and selective beta 2-agonists: spirometric synergism and oxymetric antagonism].
Díez Jarilla JL; Cruz Hernández JJ; del Pino Montes J; Sánchez Gascón F; de Portugal Alvarez J
Rev Clin Esp; 1982 Oct; 167(2):113-6. PubMed ID: 7178594
[No Abstract] [Full Text] [Related]
8. Pressurized bronchodilator aerosol technique: influence of breath-holding time and relationship of inhaler to the mouth.
Lawford P; McKenzie
Br J Dis Chest; 1982 Jul; 76(3):229-33. PubMed ID: 7126435
[No Abstract] [Full Text] [Related]
9. [The cholinergic component of airway obstruction].
Ulmer WT; Schwabl U
Fortschr Med; 1987 Jan; 105(3):43-7. PubMed ID: 2951304
[No Abstract] [Full Text] [Related]
10. [Effect of the method of inhalation of Berodual on bronchodilation in patients over 60 years of age with diffuse bronchial obstruction].
Czernicka-Cierpisz E; Kościńska M; Radomyski A; Sliwiński P; Zieliński J
Pneumonol Pol; 1988 Oct; 56(10):486-91. PubMed ID: 2978275
[No Abstract] [Full Text] [Related]
11. Possibilities of reducing the efficient dose of fenotherol by combining it with ipratropiumbromide in bronchial asthma.
Anastasatu C; Dutu S; Morgenstern H
Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():929-30. PubMed ID: 6227884
[No Abstract] [Full Text] [Related]
12. Effective site of bronchodilation by beta-adrenergic and anticholinergic agents in patients with chronic obstructive pulmonary disease: direct measurement of intrabronchial pressure with a new catheter.
Ohrui T; Yanai M; Sekizawa K; Morikawa M; Sasaki H; Takishima T
Am Rev Respir Dis; 1992 Jul; 146(1):88-91. PubMed ID: 1626821
[TBL] [Abstract][Full Text] [Related]
13. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
Morr H; Nink M; Ferlinz R
Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
[TBL] [Abstract][Full Text] [Related]
14. Nebulized fenoterol and i.v. aminophylline in acute severe asthma.
Bowler SD; Mitchell CA; Armstrong JG; Scicchitano R
Eur J Respir Dis; 1987 May; 70(5):280-3. PubMed ID: 3609188
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of a pressurized aerosol inhaler with an elongated mouthpiece].
Barliński J; Doboszyńska A; Droszcz W; Kowalski J
Pol Arch Med Wewn; 1983; 70(1-2):13-6. PubMed ID: 6359087
[No Abstract] [Full Text] [Related]
16. Influence on the depth of inhalation on the effect of the beta 2-receptor-stimulating drug fenoterol hydrobromide (berotec).
Vanderschueren RG; Laros CD; Swierenga J
Respiration; 1979; 37(6):318-27. PubMed ID: 451364
[TBL] [Abstract][Full Text] [Related]
17. The site of action of beta-2-sympathomimetic bronchodilatators in patients with chronic obstructive airway disease.
Nassari W; Zimmermann I; Bouzrina S; Ulmer WT
Respiration; 1981; 41(4):232-8. PubMed ID: 7302389
[TBL] [Abstract][Full Text] [Related]
18. [Effect duration and treatment effectiveness of salmeterol, fenoterol and salbutamol in severe forms of respiratory tract obstruction].
Vollmer M; Schmidt EW; Ulmer WT
Pneumologie; 1995 Oct; 49(10):528-34. PubMed ID: 8584522
[TBL] [Abstract][Full Text] [Related]
19. [The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases (author's transl)].
Dorow P
Arzneimittelforschung; 1978; 28(5):853-6. PubMed ID: 373776
[TBL] [Abstract][Full Text] [Related]
20. [Bronchodilator effectiveness of theophylline].
Kleinemeier HJ; Höltmann B; Schwabl U; Schwabl H; Ulmer WT
Fortschr Med; 1988 Aug; 106(24):499-502. PubMed ID: 2975627
[No Abstract] [Full Text] [Related]
[Next] [New Search]
